![](/img/cover-not-exists.png)
Randomized, Double-Blinded, Placebo-Controlled, Trial of Risedronate for the Prevention of Bone Mineral Density Loss in Nonmetastatic Prostate Cancer Patients Receiving Radiation Therapy Plus Androgen Deprivation Therapy
Choo, Richard, Lukka, Himu, Cheung, Patrick, Corbett, Tom, Briones-Urbina, Rosario, Vieth, Reinhold, Ehrlich, Lisa, Kiss, Alex, Danjoux, CyrilVolume:
85
Language:
english
Journal:
International Journal of Radiation Oncology*Biology*Physics
DOI:
10.1016/j.ijrobp.2012.11.007
Date:
April, 2013
File:
PDF, 255 KB
english, 2013